16.02.2017 • NewsElaine Burridgecancerresearch

Tusk in UK Cancer Collaboration

(c) emin kuliyev/Shutterstock
(c) emin kuliyev/Shutterstock

The UK’s Tusk Therapeutics is joining Cancer Research Technology (CRT) and University College London (UCL) to research, develop and commercialize an antibody-based therapeutic against a target known to play a key role in immune suppression in cancer.

Under the agreement’s terms, Tusk gets an exclusive worldwide licence from CRT, which is the commercial arm of charity Cancer Research UK, for therapeutic antibodies that have originated from research carried out by two experts at UCL. CRT will receive an upfront payment, future success-based milestones and royalty payments, which will be shared with UCL.

In addition, Tusk has signed a three-year collaboration with CRT and UCL to part-fund a program of preclinical work assessing antibodies in various cancer models before formal preclinical and clinical development. At the end of the collaboration, Tusk will take on responsibility for accelerating the progress of any selected candidates into the clinic.

Commenting on the partnership, Luc Dochez, CEO of Tusk Therapeutics, said: “The collaboration fits Tusk’s strategy of working with top researchers in the immuno-oncology field and to bring promising assets from early stage recovery through development and to the clinic.”

CRT’s director of business management, Phil L’Huillier, added that the project is one of several in its portfolio focused on immuno-oncology.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.